Morton Grove Pharmaceuticals, Inc. FDA Record
- Latest inspection OAI · Feb 5, 2016
- Last warning letter 2017
Morton Grove Pharmaceuticals, Inc. has 9 FDA recalls, 6 inspections, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 1 warning letter to Morton Grove Pharmaceuticals, Inc., the most recent on Feb 17, 2017. FDA has published 1 Form 483 for Morton Grove Pharmaceuticals, Inc..
- Latest recall
- D-0713-2022 · Class II · Feb 21, 2022
- Latest inspection
- Feb 5, 2016 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 9 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 2 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Morton Grove Pharmaceuticals, Inc.: FDA recall records per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 0 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 1 | 0 |
| 2019 | 0 | 0 | 0 | 1 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 0 |
| 2017 | 0 | 0 | 1 | 1 | 0 |
Reviewing Morton Grove Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Morton Grove Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Morton Grove Pharmaceuticals, Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Feb 17, 2017 · Record page |
Morton Grove Pharmaceuticals, Inc. Form 483s
| Date | Document | FEI |
|---|---|---|
| Jul 10, 2015 · Document on fda.gov | 483 | 1420913 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0713-2022 | Class II | Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By… | Feb 21, 2022 |
| D-0815-2021 | Class II | Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate… | Sep 3, 2021 |
| D-0814-2021 | Class II | Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP), 1 Pint (473 mL), Rx… | Sep 3, 2021 |
| D-0816-2021 | Class II | Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For… | Sep 3, 2021 |
| D-0174-2021 | Class II | Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL)… | Dec 9, 2020 |
| D-0130-2020 | Class II | Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx… | Sep 23, 2019 |
| D-1042-2018 | Class II | Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, 8 fl oz (237 mL) Bottle, Rx only… | Jul 24, 2018 |
| D-1125-2017 | Class II | Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when… | Aug 10, 2017 |
| D-0571-2016 | Class III | Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC… | Dec 15, 2015 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 5, 2016 | Morton Grove, IL | Drugs | Official Action Indicated (OAI) | 1420913 |
| Mar 26, 2014 | Morton Grove, IL | Veterinary | Voluntary Action Indicated (VAI) | 1420913 |
| Apr 12, 2011 | Morton Grove, IL | Drugs | Voluntary Action Indicated (VAI) | 1420913 |
| Mar 24, 2010 | Morton Grove, IL | Drugs | Voluntary Action Indicated (VAI) | 1420913 |
| Sep 17, 2009 | Morton Grove, IL | Drugs | No Action Indicated (NAI) | 1420913 |
| Mar 17, 2009 | Morton Grove, IL | Veterinary | Voluntary Action Indicated (VAI) | 1420913 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 2 compliance actions under Morton Grove Pharmaceuticals, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1420913 | Morton Grove, IL | 6 | Feb 5, 2016 |
Morton Grove Pharmaceuticals, Inc. and the FDA: common questions
Has Morton Grove Pharmaceuticals, Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Morton Grove Pharmaceuticals, Inc.. The most recent is dated Feb 17, 2017.
Has Morton Grove Pharmaceuticals, Inc. received an FDA Form 483?
FDA has published 1 Form 483 for Morton Grove Pharmaceuticals, Inc. in its reading room, the most recent dated Jul 10, 2015. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Morton Grove Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Feb 5, 2016 at Morton Grove, IL and was classified OAI. FDA has 6 inspections of Morton Grove Pharmaceuticals, Inc. on file, 1 of them classified OAI (official action indicated).
Has Morton Grove Pharmaceuticals, Inc. had an FDA recall?
Yes. Morton Grove Pharmaceuticals, Inc. has 9 FDA recalls on record. The most recent started Feb 21, 2022.
Need more than this page shows? Ask about Morton Grove Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.